Related Experiment Video
Updated: Sep 10, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Pediatric COVID-19: clinical characteristics and prognostic outcomes
Jing Chen1, Caijin Yan2, Yuling Pan3
1Department of Reproductive Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People Republic of China.
Insights
Pediatric coronavirus disease 2019 (COVID-19) infections are generally mild, but infants under one year old may experience severe respiratory symptoms. Male children show higher susceptibility to COVID-19 infection across all pediatric age groups.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Public health
Background:
- Limited data exists on coronavirus disease 2019 (COVID-19) in infants.
- Previous studies indicate less than 1% of COVID-19 cases occur in children under 10.
- Hospitalized pediatric COVID-19 cases require further analysis to understand disease impact.
Purpose of the Study:
- To analyze the clinical characteristics of pediatric COVID-19.
- To provide direction for clinical treatment and nursing of pediatric COVID-19.
- To understand COVID-19's influence on children for better public health responses.
Main Methods:
- Retrospective analysis of pediatric patients under 18 admitted with COVID-19.
- Data extraction included demographics, symptoms, clinical progression, and outcomes.
- Study period: April 2020 to January 2023.
Main Results:
- 237 pediatric COVID-19 cases were analyzed; all discharged without mortality.
- Infants under 1 year old (17.72%) had significantly higher rates of respiratory symptoms (88.09%).
- Male predominance observed (63.29%); higher proportion of asymptomatic cases in children over 10.
Conclusions:
- Pediatric COVID-19 infections are typically mild, but infants require close monitoring for respiratory distress.
- Male children exhibit increased susceptibility to COVID-19.
- Findings have implications for clinical management and public health strategies.
Abstract:
To analyze the clinical characteristics of pediatric coronavirus disease 2019 (COVID-19) and provide direction for clinical treatment and nursing. Children under 18 years old admitted to the First Affiliated Hospital of Xiamen University were collected due to testing positive for COVID-19 from the outbreak of COVID-19 to January 2023. Patient data, including age, vaccination history, admission symptoms, clinical progression, and treatment outcomes, were extracted from the database. From April 2020 to January 2023, 237 children under 18 years old with COVID-19-positive result in the pediatric ward were collected. All cases achieved hospital discharge without mortality. Among them, 17.72% were under 1 year old, 27.00% were 1-4 years old, 34.60% were 5-10 years old, and 20.68% were over 10 years old. Male predominance was observed (63.29%, sex ratio 1.72:1), the prevalence rate of children of all ages is also similar in sexual distinction (P = 0.739). Additionally, 53.16% of patients have mild symptoms; the proportion of asymptomatic COVID-19 positive children over 10 years old is higher than that of other age groups. The proportion of respiratory symptoms of children under 1 year old is significantly higher than other age groups (88.09%, P < 0.01). Convulsions manifested universally in 23 confirmed pediatric COVID-19 cases (aged 2 months-11 years). Pediatric COVID-19 infections generally manifest mild symptoms; however, infants under 1 year old exhibit more severe respiratory symptoms, necessitating escalated ventilatory support. Additionally, male children demonstrate higher susceptibility to infection compared with females across all pediatric age groups, carrying clinical and public health implications for epidemic response.
Importance:
According to a review of 72,314 cases by the China Center for Disease Control and Prevention (CDC), less than 1% of the cases occurred in children under the age of 10 years, with the vast majority being children. If children are indeed infected with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the vast majority of people will have mild diseases that do not require hospitalization. Therefore, the available data on coronavirus disease 2019 (COVID-19) in infants are still limited. This article collects the cases of children who have been hospitalized because of positive tests since the outbreak of COVID-19, analyzes, and understands how COVID-19 influences children, which can help us better interpret and respond to public health measures.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

